Ligand Pharmaceuticals Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	3,570	3,136	2,588	1,868	1,475	1,800	Upgrade
Revenue Growth (YoY)	34.69%	21.18%	38.53%	26.65%	-18.06%	-3.37%	Upgrade
Cost of Revenue	2,300	2,072	1,806	1,457	1,242	1,430	Upgrade
Gross Profit	1,270	1,063	781.99	410.67	232.71	370.09	Upgrade
Selling, General & Admin	282.89	253.15	245.54	166.53	127.57	145.34	Upgrade
Research & Development	32.62	36.54	21.04	12.18	7.17	3.97	Upgrade
Other Operating Expenses	9.12	-1.44	32.11	51.92	13.04	38.32	Upgrade
Operating Expenses	670.67	588.37	536.56	418.59	346.2	407.17	Upgrade
Operating Income	599.75	474.91	245.43	-7.92	-113.5	-37.08	Upgrade
Interest Expense	-67.58	-92.04	-53.61	-46.65	-39.94	-37.36	Upgrade
Interest & Investment Income	21.23	21.23	111.67	37.5	6.8	10.84	Upgrade
Earnings From Equity Investments	196.04	-10.84	154.46	93.99	68.28	36.48	Upgrade
Currency Exchange Gain (Loss)	-46.16	65.52	15.69	74.13	0.45	13.89	Upgrade
Other Non Operating Income (Expenses)	-6.5	-201.02	15.7	-83.05	-3	16.85	Upgrade
EBT Excluding Unusual Items	696.77	257.76	489.34	68	-80.9	3.61	Upgrade
Merger & Restructuring Charges	-	-	-	-1.5	-	-	Upgrade
Gain (Loss) on Sale of Assets	-2.86	-1.04	-2.19	-0.51	-3.8	-1.07	Upgrade
Legal Settlements	-	-	-	-4	-	-	Upgrade
Other Unusual Items	-	-	-	22.8	-19.15	-42.07	Upgrade
Pretax Income	693.91	256.72	487.15	84.8	-103.86	-39.53	Upgrade
Income Tax Expense	160.38	84.87	126.34	-4.47	-1.2	13.67	Upgrade
Earnings From Continuing Operations	533.53	171.84	360.82	89.26	-102.65	-53.2	Upgrade
Net Income to Company	533.53	171.84	360.82	89.26	-102.65	-53.2	Upgrade
Minority Interest in Earnings	0.02	0.01	0.03	0.12	0.08	0.03	Upgrade
Net Income	533.55	171.85	360.85	89.38	-102.58	-53.17	Upgrade
Net Income to Common	533.55	171.85	360.85	89.38	-102.58	-53.17	Upgrade
Net Income Growth	107.50%	-52.38%	303.71%	-	-	-	Upgrade
Shares Outstanding (Basic)	445	435	433	405	398	396	Upgrade
Shares Outstanding (Diluted)	446	436	435	407	398	396	Upgrade
Shares Change (YoY)	5.03%	0.14%	6.93%	2.39%	0.46%	-0.06%	Upgrade
EPS (Basic)	1.20	0.40	0.83	0.22	-0.26	-0.13	Upgrade
EPS (Diluted)	1.19	0.39	0.83	0.22	-0.26	-0.13	Upgrade
EPS Growth	98.11%	-53.01%	277.27%	-	-	-	Upgrade
Free Cash Flow	901.33	693.65	534.51	161.16	359.5	-20.57	Upgrade
Free Cash Flow Per Share	2.02	1.59	1.23	0.40	0.90	-0.05	Upgrade
Dividend Per Share	0.160	0.160	0.120	0.120	0.080	0.080	Upgrade
Dividend Growth	33.33%	33.33%	-	50.00%	-	-	Upgrade
Gross Margin	35.58%	33.91%	30.22%	21.98%	15.78%	20.56%	Upgrade
Operating Margin	16.80%	15.14%	9.48%	-0.42%	-7.70%	-2.06%	Upgrade
Profit Margin	14.95%	5.48%	13.94%	4.78%	-6.95%	-2.95%	Upgrade
Free Cash Flow Margin	25.25%	22.12%	20.66%	8.63%	24.37%	-1.14%	Upgrade
EBITDA	956.23	789.34	502.9	196.32	96.5	184.21	Upgrade
EBITDA Margin	26.78%	25.17%	19.43%	10.51%	6.54%	10.23%	Upgrade
D&A For EBITDA	356.48	314.43	257.47	204.24	209.99	221.29	Upgrade
EBIT	599.75	474.91	245.43	-7.92	-113.5	-37.08	Upgrade
EBIT Margin	16.80%	15.14%	9.48%	-0.42%	-7.70%	-2.06%	Upgrade
Effective Tax Rate	23.11%	33.06%	25.93%	-	-	-	Upgrade

Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.